U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07522736) titled 'Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery' on April 04.
Brief Summary: This study aims to compare the duration of analgesia (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine with hyperbaric bupivacaine to patients undergoing knee orthopedic surgery.
Study Start Date: March 01, 2025
Study Type: INTERVENTIONAL
Condition:
Intrathecal Dexmedetomidine
Bupivacaine
Knee Orthopedic Surgery
Intervention:
DRUG: Dexmedetomidine 4 μg
Patients will receive intrathecal hyperbaric bupivacaine 15 mg, supplemented...